Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung Cancer
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
In this multicenter trial, we plan to evaluate the feasibility and toxicity of initial
treatment with irinotecan/carboplatin/radiation therapy, followed by treatment with
bevacizumab, in patients with limited stage small cell lung cancer.